Skip to main content
TipRanks
Go Ultimate75% OFF

fureasu Co., Ltd. (7062) AI Stock Analysis

0 Followers
JP:7062

fureasu Co., Ltd.

(TSE/TYO:7062)

Select Model
Rating:71Outperform
Price Target:JPY 745.00â–²(12.20% Upside)
Action:reiterated
Date:11/18/26

fureasu Co., Ltd. scores reasonably well due to a remarkable fundamental turnaround and a deeply undervalued profile (P/E of 4.84). Aggressive debt reduction, returning profitability, and robust cash flow strongly support its intrinsic value. However, the score is heavily constrained by persistent negative technical momentum, as the stock remains entrenched in a steady downtrend below all key moving averages.

Positive Factors
Profit and Margin RecoveryFY2026’s return to positive net income and operating profit, alongside gross-margin expansion, indicates improved operating economics. If sustained, this recovery can rebuild earnings capacity and provide more internal funding for the home-visit network over coming quarters.
Negative Factors
Revenue DeclineRevenue contraction indicates that the profit recovery has not yet been accompanied by top-line expansion. Continued volume or sales pressure could limit operating leverage, constrain the home-visit network’s growth, and make future earnings more dependent on cost control.

fureasu Co., Ltd. (7062) vs. iShares MSCI Japan ETF (EWJ)

-20%-10%0%10%20%30%40%JP:7062-14.87%EWJ+15.53%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
JPY 1.72B
Dividend Yield
1.57%
Average Volume (3M)
3,891
Price to Earnings (P/E)
4.8
Beta (1Y)
0.73
Revenue Growth
-27.05%
EPS Growth
387.17%
Country
Japan
Employees
761
Sector
General
Sector Strength
55
Industry
Medical - Care Facilities

fureasu Co., Ltd. Business Overview & Revenue Model

Company Description

Fureasu Co.,Ltd. is a Japanese company specializing in therapeutic massage services, massage franchise operations, and a diverse range of care solutions. Its therapeutic offerings encompass in-home acupuncture, moxibustion treatments, on-site corpora...

How the Company Makes Money

Fureasu Co., Ltd. primarily makes money by charging for home-visit treatment services (e.g., acupuncture/moxibustion) delivered to clients; revenue is generated when a practitioner visit is performed and billed. The company also earns revenue through...

fureasu Co., Ltd. Financial Statement Overview

Summary

Strong financial turnaround characterized by a return to solid profitability (6.66% net margin), robust free cash flow generation, and aggressive deleveraging that lowered the debt-to-equity ratio to 0.98. An exceptional 23.3% ROE further reflects highly efficient capital use.

Income Statement

75Positive

Balance Sheet

80Positive

Cash Flow

85Very Positive
Financial statement breakdown
BreakdownTTMMar 2026Mar 2025Mar 2024Mar 2023Mar 2022
Income Statement
Total Revenue6.85B7.64B7.58B5.71B4.58B4.17B
Gross Profit3.29B3.46B3.20B2.69B2.24B2.08B
EBITDA956.16M482.72M200.26M319.35M200.51M332.47M
Net Income604.17M508.92M-244.55M58.30M31.59M147.85M
Balance Sheet
Total Assets5.19B5.39B8.70B6.19B4.54B3.39B
Cash, Cash Equivalents and Short-Term Investments1.36B1.62B815.00M1.13B975.26M1.21B
Total Debt2.03B2.14B6.14B3.48B2.09B995.35M
Total Liabilities3.01B3.21B7.15B4.43B2.81B1.67B
Stockholders Equity2.18B2.18B1.55B1.77B1.73B1.72B
Cash Flow
Free Cash Flow0564.46M-456.86M41.91M-317.08M166.38M
Operating Cash Flow0590.56M-319.20M172.02M-233.15M309.27M
Investing Cash Flow0801.62M-354.88M-193.60M-516.91M-149.47M
Financing Cash Flow0-589.96M358.26M177.13M511.11M-160.97M

fureasu Co., Ltd. Technical Analysis

Technical Analysis SentimentNegative
Last Price664.00

Price Trends

50DMA682.02Negative
100DMA720.17Negative
200DMA773.57Negative

Market Momentum

MACD-3.38Negative
RSI46.50Neutral
STOCH75.61Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:7062, the sentiment is Negative. The current price of 664.00 is below the 20-day moving average (MA) of 676.25, below the 50-day MA of 682.02, and below the 200-day MA of 773.57, indicating a bearish trend. The MACD of -3.38 indicates Negative momentum. The RSI at 46.50 is Neutral, neither overbought nor oversold. The STOCH value of 75.61 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:7062.

fureasu Co., Ltd. Peers Comparison

Overall Rating

UnderperformOutperform
Sector (55)

Financial Indicators

JP:7062 against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
JP:7358JP:735874OutperformJPY 16.39B10.36―2.66%8.02%47.33%
JP:9262JP:926274OutperformJPY 6.95B8.39―2.83%8.68%16.99%
JP:7062JP:706271OutperformJPY 1.76B4.84―1.57%-27.05%387.17%
JP:7040JP:704061NeutralJPY 5.71B11.09―3.76%0.57%-38.90%
Sector *55Neutral$6.65B3.83-15.92%6.20%10.91%7.18%
JP:4331JP:433150NeutralJPY 11.79B61.95―6.29%――

* General Sector Average

Performance Comparison

-20%0%20%40%JP:7062JP:4331JP:7040JP:7358JP:9262Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
JP:7062 and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
JP:7062fureasu Co., Ltd.664.00-121.00-15.41%
JP:4331Take and Give. Needs Co., Ltd.797.0081.3811.37%
JP:7040SUN-LIFE HOLDING CO., LTD.926.007.440.81%
JP:7358Poppins Corporation1664.00347.3526.38%
JP:9262SILVER LIFE CO.,LTD.628.00-215.88-25.58%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Nov 18, 2026